T cells in the liver: There is life beyond the graveyard - Commentary

Hepatology

Volumn 45, Issue 6, 2007, Pages 1580-1582

  Bertolino, Patrick ^a   Bowen, David G ^a   Benseler, Volker ^a  

^a CENTENARY INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; CD8+ T LYMPHOCYTE; CELL DEATH; CELLULAR IMMUNITY; FLOW CYTOMETRY; INFLUENZA; INFLUENZA VIRUS; INFLUENZA VIRUS A; LIVER FUNCTION; MOUSE; NONHUMAN; NOTE; PRIORITY JOURNAL; SURVIVAL;

EID: 34250348347     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21786     Document Type: Note

References (19)

1. Huang L, Soldevila G, Leeker M, Flavell R, Crispe IN. The livet eliminates T cells undergoing antigen-triggered apoptosis in vivo. Immunity 1994;1:741-749.
2. Bertolino P, Glimpel G, Lemon SM. Hepatic inflammation and immunity: a summary of a conference on the function of the immune system within the liver. HEPATOLOGY 2000;31:1374-1378.
3. Crispe IN, Dao T, Klugewitz K, Mehal WZ, Metz DP. The liver as a site of T-cell apoptosis: graveyard, or killing field? Immunol Rev 2000;174:47-62.
4. Crispe IN, Giannandrea M, Klein I, John B, Sampson B, Wuensch S. Cellular and molecular mechanisms of liver tolerance. Immunol Rev 2006;213:101-118.
5. Keating R, Yue W, Rutigliano JA, So J, Olivas E, Thomas PG, Doherry PC. Vitus-specific CD8+ T cells in the liver: armed and ready to kill. J Immunol 2007;178:2737-2745.
6. Shoukry NH, Cawthon AG, Walker CM. Cell-mediated immunity and the outcome of hepatitis C vitus infection. Annu Rev Microbiol 2004;58:391-424.
7. Girgis L, Davis MM, Fazekas de St Groth B. The avidity specttum of T cell receptor interactions accounts for T cell anergy in a double transgenic model. J Exp Med 1999;189:265-278.
8. Bowen DG, McCaughan G, Bertolino P. Intrahepatic immunity: a tale of two sites? Trends Immunol 2005:26:512-517.
9. Ando K, Guidotti LG, Cerny A, Ishikawa T, Chisari FV. CTL access to tissue antigen is restricted in vivo. J Immunol 1994;153:482-488.
10. Mehal WZ, Juedes AE, Crispe IN. Selective retention of activated CD8+ T cells by the normal liver. J Immunol 1999;163:3202-3210.
11. Hamann A, Klugewitz K, Austrup F, Jablonski-Westrich D. Activation induces rapid and profound alterations in the trafficking of T cells. Eur J Immunol 2000:30:3207-3218.
12. Klugewitz K, Adams DH, Emoto M, Eulenburg K, Hamann A. The composition of intrahepatic lymphocytes: shaped by selective recruitment? Trends Immunol 2004;25:590-594.
13. Russell JQ, Morrissette GJ, Weidner M, Vyas C, Aleman-Hoey D, Budd C. Liver damage preferentially results from CD8+ T cells triggered by high affinity peptide antigens. J Exp Med 1998;188:1147-1157.
14. Mehal WZ, Azzaroli F, Crispe IN. Antigen presentation by liver cells controls intrahepatic T cell trapping, whereas bone marrow-derived cells preferentially promote intrahepatic T cell apoptosis. J Immunol 2001;167:667-673.
15. Bowen DG, Warren A, Davis T, Hoffmann MW, McCaughan GW, Fazekas de St Groth BF, et al. Cytokine-dependent bystander hepatitis due to intrahepatic murine CD8+ T-cell activation by bone marrow-derived cells. Gastroenterology 2002;123:1252-1264.
16. Limmer A, Ohl J, Kurts C, Ljunggren HG, Reiss Y, Groettrup M, et al. Efficient presentation of exogenous antigen by liver endorhelial cells to CD8+ T cells results in antigen-specific T-cell tolerance. Nat Med 2000;6:1348-1354.
17. Winau F, Hegasy G, Weiskirchen R, Weber S, Cassan C, Sieling PA, et al. Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity 2007;26:117-129.
18. Polakos NK, Cornejo JC, Murray DA, Wright KO, Treanor JJ, Crispe IN, et al. Kupffer cell-dependent hepatitis occurs during influenza infection. Am J Pathol 2006;168:1169-1178.
19. Markin RS. Manifestations of Epstein-Barr virus-associated disorders in liver. Liver 1994;14:1-13.